PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...
Patients With a Low Corus CAD Score Had 94% Reduced Odds of Referral to a Cardiologist; REGISTRY I Study Results Add to the Established Evidence Base Supporting the Clinical Utility of the Corus CAD ...
REDWOOD CITY, CA--(Marketwired - Oct 20, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of the study, "The Use of a ...
Patients diagnosed with nonobstructive coronary artery disease (CAD) are at increased risk of myocardial infarction (MI) and mortality over the next year compared with those classified as having no ...
It's been a difficult year for CardioDx, but there may be light at the end of the tunnel: In a new study, researchers found that the company's genetic test for coronary artery disease could help ...
Use of computer-aided detection (CAD) software to analyze and interpret mammograms does not improve the accuracy, finds study published in Journal of the National Cancer Institute. CAD software, used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results